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Historical perspective
Early postmortem studies 
chizophrenia is a heterogeneous disorder with
variations in expression and, likely, pathophysiology.
There is no one symptom that is the sine qua non of
schizophrenia, and variations in symptoms occur even in
the same patient. Motivation, cognition, memory, exec-
utive functioning, affect, and social communication are
all altered in schizophrenia. Moreover, this disorder has
been described for more than 100 years, and yet the neu-
ropathology of schizophrenia is still unknown, and this
is despite the fact that both Kraepelin
1 and Bleuler,
2 who
first described “dementia praecox” and “the schizo-
phrenias,” believed that brain abnormalities would ulti-
mately be linked to the etiology of schizophrenia (see
review in ref 3). These early speculations by Kraepelin
and Bleuler were further fueled by important inroads
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Historically, Kraepelin speculated that dementia prae-
cox resulted from damage to the cerebral cortex, most
notably the frontal and temporal cortices. It is only
recently, however, that tools have been available to
test this hypothesis. Now, more than a century later,
we know that schizophrenia is a brain disorder. This
knowledge comes from critical advances in imaging
technology—including computerized axial tomogra-
phy, magnetic resonance imaging, and diffusion imag-
ing—all of which provide an unprecedented view of
neuroanatomical structures, in vivo. Here, we review
evidence for structural neuroimaging abnormalities,
beginning with evidence for focal brain abnormalities,
primarily in gray matter, and proceeding to the quest
to identify abnormalities in brain systems and circuits
by focusing on damage to white matter connections in
the brain. We then review future prospects that need
to be explored and pursued in order to translate our
current knowledge into an understanding of the neu-
robiology of schizophrenia, which can then be trans-
lated into novel treatments.  
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PAGES_DCNS 46_5.qxd:DCNS#45  9/09/10  9:39  Page 317that were being made around this same time period into
Huntington’s chorea, Pick’s disease, epilepsy, tertiary
syphilis, and Alzheimer’s disease.
4-8 Of note here,
Alzheimer was among the first to study the neu-
ropathology of schizophrenia, although he went on to
investigate what he thought of as more tractable brain
disorders. In addition, findings from postmortem stud-
ies, also conducted during this same time period, were
disappointing as they frequently led to conflicting find-
ings largely due to the crude measurement tools that
were available, and to the high expectations that
researchers had of finding large abnormalities, similar to
what had been observed for diseases such as Pick’s dis-
ease and tertiary syphilis.
3,4-8As it turns out, such abnor-
malities have been shown to be far smaller and more
subtle than researchers had originally believed would be
the case.
3This state of affairs led Plum,
9 in 1972, to state
that “schizophrenia is the graveyard of neuropatholo-
gists.” 
CT and MRI are introduced
Research interest in investigating brain abnormalities in
schizophrenia thus waned until 1976, when the first com-
puted tomography (CT) study showed enlarged lateral
ventricles in schizophrenia.
10 Following this study, a large
number of CT and magnetic resonance imaging (MRI)
studies followed, with the first MRI study of schizo-
phrenia conducted in 1984 by Smith and coworkers.
11
The first quantitative MRI study of schizophrenia was
subsequently conducted by Andreasen and coworkers in
1986,
12 and the first quantitative MRI study that included
contiguous slices of the entire brain and correlations
with specific clinical symptoms was conducted by
Shenton and coworkers in 1992.
13
An example of a CT scan is depicted in Figure 1, which
shows a clear differentiation between bone, brain, and
cerebrospinal fluid (CSF). In contrast, the differentiation
between gray matter and white matter (ie, soft tissue) is
not very clear using CT. The ability to differentiate
between gray and white matter tissue had to await the
introduction of magnetic resonance imaging (Figure 2). 
Parenthetically, and of historical interest here, following
the introduction of CT, nuclear magnetic resonance
(NMR), as it was called then, was developed in the early
1970s based on the work of Peter Mansfield
14 and Paul
Lauterbur.
15 These individuals went on to share the
Nobel Prize in Medicine in 2003 for their independent
contributions to the seminal ideas that led to MRI and
its application, in vivo, to humans. Importantly, MRI has
no known adverse effects (ie, no radiation as in X-rays
and CT), and it is a far more powerful tool than CT for
visualizing soft tissue contrast in the brain and body. 
The first MR scanners were built in the 1980s, with, as
noted above, the first MRI of a patient with schizophre-
nia performed in 1984. These early MR images of the
brain were quite poor in resolution, with slices as thick
as 1 cm, and they did not cover the entire brain. This is
in contrast to major advances in technology today, where
1-mm slice thickness is common, and it is relatively easy
to image the entire brain in a relatively short period of
time. Today, in fact, MR scanners are used routinely to
measure tissue properties in the brain and body at sub-
millimeter spatial resolution, based on the NMR of
hydrogen in the magnetic field. 
Put even more into perspective, the ability to examine
the inner workings of the human body was limited, his-
torically, to the study of cadavers. Advances in medical
imaging technology, however, have provided researchers
with a new window into the living human body. Such
Translational research
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Figure 1. This CT scan shows separation of brain from fluid, including
CSF and blood. This is a CT scan, post-contrast, of a patient
with a bleed from an aneurysm (black color is blood and CSF).
CT, computed tomography; CSF, cerebrospinal fluid
PAGES_DCNS 46_5.qxd:DCNS#45  9/09/10  9:39  Page 318advances have revolutionized nearly every area of med-
icine, with psychiatry in the forefront of this revolution.
These advances include both dramatic improvements in
image resolution and the development of novel imaging
techniques, from CT to positron emission tomography
(PET), to single-photon emission computed tomography
(SPECT), to MRI, including functional MRI (fMRI) and
diffusion tensor imaging (DTI), to magnetic resonance
spectroscopy (MRS), and ultrasound—all of which pro-
vide an unprecedented view, in exquisite detail, of
anatomical structures and/or functions in the living
human. 
To return to the discussion of MRI, it is noteworthy that
between 1984 and the present there has been a bur-
geoning of MRI studies in schizophrenia. Further, dur-
ing this 26-year time period there are more definitive
findings with respect to brain abnormalities in schizo-
phrenia than have been documented in any previous
time period in the history of schizophrenia research.
Figure 3 shows the number of MRI studies conducted,
each year, from 1984 to 2010, based on a PubMed search
using the terms: schizophrenia, MRI, magnetic reso-
nance imaging, and neuroimaging. What is evident here
is the increase over time in the number of MRI studies:
from 1 in 1984, to 71 in 1994, to 514 in 2004, to 786 in
2009 (Total =6305). These studies have led to a wealth of
knowledge about the brain and schizophrenia—knowl-
edge that would not have been possible without the rev-
olutionary advances in neuroimaging technology.
Acquisition and post-processing techniques have also con-
tinued to advance and it is now possible to segment the
brain, automatically, into gray matter, white matter, and
CSF, as well as to delineate small brain regions of interest.
The segmentation of brain into tissue classes seems a triv-
ial task today, but it required more than 15 years of com-
puter vision research to make this a reality. We tend to
take for granted many of the postprocessing tools that we
have available today, including software packages that
enable registration, segmentation, tractography, and region
of interest delineations, eg, Slicer (http://www.slicer.org),
Brain Voyager (http://www.brainvoyager.com/), Brains2
(http://www.psychiatry.uiowa.edu/mhcrc/IPLpages/BRAI
NS.htm), SPM (http://www.fil.ion.ucl.ac.uk/spm/), and
FreeSurfer (http://surfer.nmr.mgh.harvard.edu/). These
tools, in fact, were many years in the making and have sig-
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Figure 2. This MR scan shows one coronal slice through the superior
aspects of the lateral ventricles. Note the clear differentiation
between gray and white matter. Gray matter appears gray and
can be seen in the ribbon around the cortex, as well as in sub-
cortical brain regions. White matter appears white, and the
lateral ventricles are black. MR, magnetic resonance
Figure 3. Graph of MRI studies in schizophrenia between 1984 and April
2010. MRI, magnetic resonance imaging
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PAGES_DCNS 46_5.qxd:DCNS#45  9/09/10  9:39  Page 319nificantly improved our ability to segment the brain and
to investigate more precisely brain abnormalities in schiz-
ophrenia and other disorders, compared with healthy con-
trols. Furthermore, the fact that these tools are more auto-
mated means that a larger number of subjects can be
evaluated in a shorter amount of time than was possible
using only manually driven methods to characterize brain
regions of interest. These advances also make it possible
to register brains at follow-up to baseline, in order to com-
pare differences over time, and we are now able to use
multiple imaging techniques in the same subject, which
maximizes our opportunity to combine information from
functional and structural measures of the brain.
New imaging tools today involve the application of
imaging technology to map the structure and function of
brain, the latter of which includes functional imaging, a
topic which is not reviewed here as it is reviewed else-
where in this issue. Most of the structural imaging stud-
ies, to date, have investigated gray matter, including lon-
gitudinal studies that show progression of gray matter
abnormalities following first episode of illness (eg, refs
16,17), with far less attention to the role of white matter
abnormalities in schizophrenia. 
Diffusion imaging is introduced
The development of diffusion tensor imaging (DTI) has
made it possible to investigate white matter in the brain,
in vivo, in a manner not possible with conventional MRI.
The work that led to the first imaging of white matter in
humans began with the work of Steiskal and Tanner
18 in
1965, followed by the work of Le Bihan et al
19 in 1986
who introduced diffusion MR, and Basser et al
20 in 1994,
who developed DTI. The first DTI of the human brain
was conducted by Pierpaoli et al
21 in 1996, and the first
DTI study in patients with schizophrenia was conducted
by Buchsbaum et al
22 in 1998. These time periods are
highlighted to emphasize just how recently this technol-
ogy has been developed. 
The basic principle underlying diffusion imaging is that
the diffusion of water molecules is restricted equally in
all directions in CSF (isotropic diffusion), and not
restricted equally in white matter, where it exhibits
strong anisotropic diffusion, or in gray matter, where it
exhibits weak anisotropic diffusion. By calculating the
distance that water diffuses from a given point in a given
time period, in a number of directions, it is possible to
construct a three-dimensional shape that describes the
diffusion, ie, an ellipsoid, with the shape and size of the
ellipsoid providing information about the underlying tis-
sue. The two most common diffusion measures used are
fractional anisotropy (FA, shape of ellipsoid) and mean
diffusivity (MD, size of ellipsoid). 
FA is a measure of the anisotropy or nonsphericity of
the shape of the diffusion ellipsoid. FA varies between
0 and 1, with the most isotropic diffusion having a
value of 0 and the most anisotropic diffusion having
a value of 1. FA decrease is generally thought to reflect
damage to myelin or axons, reduced axonal density,
and/or reduced axonal coherence (see review in
Kubicki et al
23). In contrast, MD provides quantitative
information about the size of the diffusion ellipsoid, or
the average displacement of water molecules resulting
from diffusion at a given point in time. MD is highest
in tissues where there are fewer restrictions to diffu-
sion (eg, CSF), and lowest in tissues where diffusion is
restricted by densely packed tissue elements (ie, cells).
In schizophrenia studies, reviewed later in this chap-
ter, FA and MD are the most common measures used,
with decreased FA and increased MD consistently
evinced by patients with schizophrenia. As mentioned
above, these diffusion abnormalities likely reflect sub-
normal levels of fiber coherence, demyelination/dys-
myelination, and/or subnormal levels of axon packing
density.
Figure 4 provides a graph depicting the number of dif-
fusion imaging studies that have investigated white mat-
ter pathology in schizophrenia, each year, starting with
Buchsbaum et al’s
22 first diffusion tensor imaging study
in 1998 (Total =178 compared with 6305 MRI studies).
The focus on white matter fiber bundles is important
because for the first time it is possible to investigate con-
nections between brain regions, which, along with func-
tional measures, will likely lead to a new understanding
of the neural circuits and their function and dysfunction
in schizophrenia. Figure 5 shows a fractional anisotropy
map (Panel A), as well as a color map (Panel B) that
depicts the directionality of white matter along the x, y,
and z axes. A 3D reconstruction of several white matter
fiber tracts extracted from diffusion images of the brain
is shown in Figure 6. This relatively new technology has
become the major tool in neuroscience for investigating
white matter, in vivo, and it shows great promise for elu-
cidating further white matter fiber tracts that subserve
neuroanatomical connections between both distant and
proximal brain regions.
Translational research
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With respect to schizophrenia, the question is therefore
not: “are brain abnormalities present in schizophrenia?”
but, “what is the nature of these abnormalities and how
can we use this information to understand better the
neurobiology of schizophrenia so that we can develop
more targeted treatments and perhaps neuroprotective
agents to prevent the cascade of progressive changes
that are often reported in chronic cases of schizophre-
nia?”
3,23-26 Below, we review structural neuroimaging find-
ings in schizophrenia, both MRI and DTI, although we
refer the reader to several recent and more comprehen-
sive reviews covering these same topics.
3, 23-26
MRI findings in schizophrenia
Prior to the advent of MRI, brain abnormalities in schiz-
ophrenia were based on crude measurements such as
measuring the volume of plaster casts from postmortem
brains, and pneumoencephalographic studies,
27-30 both of
which were used to measure ventricular size. The latter
studies were quite invasive as they involved pushing air
into the brain cavity. Many of these studies, nonetheless,
along with CT studies (eg, ref 10), described above,
showed enlarged ventricles in the brains of patients with
schizophrenia. 
MRI studies of schizophrenia have also observed ven-
tricular enlargement in schizophrenia (see reviews, eg,
refs 3,23-26), with approximately 80% of MRI studies
reporting this enlargement.
3 Enlarged lateral ventricles,
however, are not pathognomonic of schizophrenia, as
they are also observed in hydrocephalus, Alzheimer’s
disease, and other neurodegenerative diseases where
brain is replaced by CSF. Of further note, since the com-
prehensive review by the first author in 2001,
3 MRI
findings in schizophrenia are relatively similar in terms
of the percentage of studies showing abnormalities.
More specifically, in the 2001 review it was observed
that 80% of the studies revealed enlarged lateral ven-
tricles, 73% revealed enlarged third ventricles, and there
was a preferential involvement of medial temporal lobe
structures (74%) that included amygdala, hippocampus,
parahippocampal gyrus, and neocortical temporal lobe
structures, ie, superior temporal gyrus (100% if gray and
white matter were differentiated), and moderate evi-
dence for frontal lobe involvement (59% of studies),
most notably prefrontal cortex and orbitofrontal cortex.
Other brain regions involved, and reported in this ear-
lier review, included parietal lobe abnormalities (60%
of studies), particularly inferior parietal lobule, which
includes supramarginal gyrus and angular gyrus. Other
findings included subcortical abnormalities, including
cavum septum pellucidum (92% of studies), basal gan-
glia (68% of studies), corpus callosum (63% of studies),
thalamus (42% of studies), and cerebellum (31% of
Structural neuroimaging in schizophrenia - Shenton et al Dialogues in Clinical Neuroscience - Vol 12 . No. 3 . 2010
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Figure 4. Graph of DTI studies in schizophrenia between 1998 and April
2010. DTI, diffusion tensor imaging
DTI studies on schizophrenia
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Figure 5. The anisotropy map in the left panel shows increased fractional
anisotropy (FA) in areas where the water diffusion is restricted,
such as in the corpus callosum. Areas with increased FA are
visible as white. The color map in the right panel shows the
directions of the diffusion in x, y, z space, with the colors red,
blue, and green, respectively. 
PAGES_DCNS 46_5.qxd:DCNS#45  9/09/10  9:39  Page 321studies). These numbers have not changed appreciably
with the increase in MRI studies since 2001, but they do
highlight the fact that there are multiple focal brain
regions that are abnormal in schizophrenia, which are
not necessarily proximal but which may nonetheless be
involved in brain circuits that are abnormal in schizo-
phrenia. 
Moreover, and as was noted in the 2001 review, the tim-
ing of these abnormalities is still not known, although
more recent studies, reviewed below, suggest that
changes occur over time, particularly soon after onset of
illness, and these changes may also be evident before the
onset of symptoms (ie, in the prodrome period).
Abnormalities are also observed, albeit in a more atten-
uated form, in family members of patients with schizo-
phrenia.
The question, then, as noted above, and as noted by
Harrison,
31 is thus not whether there are brain abnor-
malities in schizophrenia, as this is clearly confirmed.
The question is rather “what sort of brain disorder is
schizophrenia? Is it static? Is it progressive?” Further,
if brain abnormalities change over time, does this nec-
essarily mean that schizophrenia is a neurodegenerative
disorder, or is it more likely that schizophrenia is asso-
ciated with the unfolding of neurodevelopmental
processes, which may show progression over time?
Translational research
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Figure 6. Three-dimensional image reconstructed based on diffusion data acquired on a 3T GE scanner at Brigham and Women’s Hospital, Harvard
Medical School, Boston, MA. This image shows several major white matter fiber bundles identified through diffusion tensor imaging: fornix
(magenta), right cingulum (green), right inferior longitudinal fasciculus (yellow), right uncinate fasciculus (blue), corpus callosum (orange). 
Adapted from ref 24: Shenton ME, Kubicki M. Structural brain imaging in schizophrenia. In: Sadock BJ, Sadock VA, Ruiz P, eds. Sadock’s Comprehensive
Textbook of Psychiatry. 9th ed. New York: NY: Lippincott Williams, and Wilkins; 2009:1494-1506. Copyright © Lippincott, Williams and Wilkins, 2009.
PAGES_DCNS 46_5.qxd:DCNS#45  9/09/10  9:39  Page 322Perhaps, for example, changes over time suggest abnor-
malities in brain maturation or a developmental lesion,
which in some cases is limited but in other cases takes
on a more neurodegenerative course, as postulated in
the early part of the twentieth century by Kraepelin.
1
Furthermore, are the two theories, neurodevelopmen-
tal versus neurodegenerative, necessarily mutually
exclusive? Other questions to be addressed include:
“Are some brain abnormalities more evident prior to
the onset of schizophrenia, and in the prodrome period,
or at first onset, while other brain abnormalities become
evident later, as the disorder progresses?”—These are
among the questions that need to be answered in order
to understand further the neurobiology of schizophre-
nia.
To hold stringently, however, to the view that schizo-
phrenia is either a neurodevelopmental disorder or a
neurodegenerative disease is short-sighted. Development
does not end at birth, but instead continues throughout
the lifespan and involves critical periods of development,
particularly in the periadolescent period, with the timing
of disease sometimes linked to genetics, such as with
Huntington’s disease, which may not manifest itself until
later in life. 
Feinberg
32 appreciated the notion that development is
not static and that it occurs across the lifespan. He
observed that development may proceed normally up to
adolescence, which he viewed as a critical time period
when faulty programming leads to abnormalities in
synaptic pruning in those adolescents who go on to
develop schizophrenia. Mednick and McNeil
33 also had
a broad view of neurodevelopment, and of the progres-
sion of illness. They described a “two-hit” model of schiz-
ophrenia, where genetics, and/or possible assaults dur-
ing neurodevelopment, comprised the “first hit.” They
believed, however, that schizophrenia did not develop
without a “second hit,” which occurs later in develop-
ment, around the time of adolescence or early adult-
hood. Thus a broad view of neurodevelopment, which
includes the possibility of disease progression, has been
proposed in the past and needs to be more appreciated
today when we evaluate the role of brain abnormalities
in schizophrenia. 
More recent MRI findings, reviewed below, suggest that
changes in the brain are observable at or even before the
first onset of psychosis, with post-onset changes observed
in a relatively short time period following illness onset.
Progressive changes, however, in and of themselves, do
not provide evidence that schizophrenia is a neurode-
generative disorder. More recent MRI findings have,
nonetheless, rekindled an interest in neurodegenerative
theories of schizophrenia, although it is clear that early
motor abnormalities, neurological soft signs prior to ill-
ness onset, sulco-gyral pattern abnormalities and cavum
septum pellucidum abnormalities commonly exhibited
by patients with schizophrenia point to the important
role of neurodevelopment in schizophrenia (see review
in Shenton et al
3). There is also no evidence for a loss of
neurons and no gliosis in postmortem studies of schiz-
ophrenia.
34 These findings, taken together, suggest that
schizophrenia is not a neurodegenerative disorder, at
least not as defined by conventional criteria. 
A better question then, is: “Do some patients show pro-
gressive changes following onset of first episode of ill-
ness, while others do not? And if so, what factors con-
tribute to these differences, and what are the
implications with respect to treatment and outcome?”
Other issues that need to be addressed include evaluat-
ing brain abnormalities in high-risk individuals and in
the unaffected family members of patients with schizo-
phrenia. Still another question that needs to be
addressed is whether or not early treatment will make a
difference in the course of the illness. Further, will treat-
ing high-risk individuals provide neuroprotective effects
that prevent the development of schizophrenia? Finally,
research needs to focus on determining the specificity of
findings to schizophrenia. All of these issues need to be
addressed as research moves toward unraveling what
“sort of disease schizophrenia is”; a theme we will return
to multiple times in this review.
MRI findings in chronic patients
There have been a large number of MRI studies inves-
tigating brain abnormalities in chronic schizophrenia.
What is surprising is that from 2001 to the present,
3 even
though most studies have moved from 1.5T to 3T mag-
nets, and the image resolution has increased, the find-
ings, as noted previously, have not changed appreciably.
Moreover, and importantly, most of these studies have
focused on gray matter. This focus is understandable as
it is more difficult to appreciate white matter fiber bun-
dles with structural MRI. New measures that comple-
ment volume measures have also been introduced and
are more commonplace now, including shape measures,
Structural neuroimaging in schizophrenia - Shenton et al Dialogues in Clinical Neuroscience - Vol 12 . No. 3 . 2010
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cal folding measures (see reviews covering these issues,
eg, refs 23-26). The consistency of findings, nonetheless,
is quite striking and reveals multiple brain regions that
show gray matter abnormalities in chronic schizophre-
nia including brain regions within the prefrontal, tem-
poral, parietal, and occipital lobe. 
The list of brain regions reported as abnormal is, in fact,
quite long and includes: whole gray matter, whole white
matter, CSF, lateral ventricles, third ventricle, ventricular
CSF, subarachnoid CSF, prefrontal cortex, dorsolateral
prefrontal cortex, orbitofrontal cortex, cavum septum pel-
lucidum, cingulate gyrus, anterior cingulate gyrus, thala-
mus, amygdala, hippocampus, planum temporale, Heschl’s
gyrus, cerebellum, insular cortex, nucleus accumbens, stria-
tum, superior temporal gyrus, olfactory bulb, basal ganglia,
putamen, caudate, globus pallidus, parahippocampal gyrus,
fusiform gyrus, cerebellar hemispheres, cerebellar vermis,
parieto-occipital lobe, perigenual regions, pituitary, pre-
central sulcus, entorhinal cortex, occipital lobe, temporal
lobe, pons, Sylvian fissure, adhesio interthalamica, and
pineal gland (see reviews in refs 3,23-26). These abnor-
malities also include associations between brain abnor-
malities and cognitive/clinical symptoms in schizophrenia.
The latter include, but are not limited to, deficit symptoms
and prefrontal cortex abnormalities, impairments in insight
and frontal-lobe abnormalities, impairments in social cog-
nition and anterior cingulate abnormalities, impairments
in error detection and cingulate gyrus abnormalities,
impairments in face recognition and fusiform gyrus and
amygdala abnormalities, hallucinations and superior tem-
poral gyrus abnormalities, language disturbances and
medial temporal lobe abnormalities, and formal thought
disorder and both superior temporal gyrus and posterior
temporal lobe abnormalities, to name just a few (see
reviews, eg, refs 3,23-26).
It will be important, as we move forward, to begin asso-
ciating such findings with other imaging modalities such
as fMRI and white matter fiber tract measures derived
from DTI, in order to understand further brain abnor-
malities and what they tell us about brain systems and
circuits. We also need to tease apart more definitively
what is intrinsically a signature, or marker, of the disor-
der, and what is associated with epiphenomena. Here,
evaluating first-episode patients is important because the
effects of long-term medication and chronicity can be
ruled out as possible confounds, and putative markers
can be discovered and better delineated from the
epiphenomena of the illness. Additionally, investigating
first-episode patients, and prodromal subjects (ie, those
who are at high risk for schizophrenia but have as yet
not developed it), may lead to important new inroads
that will make early intervention possible in order to
help prevent this disorder from taking hold and/or
becoming chronic.
MRI findings in first-episode patients and longitudinal
studies
DeLisi and colleagues
35 were among the first to conduct
cross-sectional and longitudinal studies of first-episode
patients with schizophrenia. These investigators followed
patients for 10 years and reported lateral ventricular
enlargement and reduced volumes in the cerebrum, cere-
bellum, and corpus callosum. However, DeLisi and col-
leagues
35 failed to identify volume reductions in the
frontal or temporal lobes, or in more circumscribed
regions of interest within these lobes, compared with
healthy controls. In contrast, DeGreef et al
36 reported no
enlarged ventricles in first-episode patients, though their
follow-up was only over a short period of 1 to 2 years.
Also in contrast to DeLisi et al’s findings, more recent
studies have reported volume reduction in the frontal
lobes, including Gur and colleagues
37 who reported
reduced volume in the frontal lobe at 2 to 3 years' follow-
up in first-episode patients, and Ho and colleagues
38 who
reported similar findings. Additionally, Kasai and col-
leagues
16 reported reduced volume in the left superior
temporal gyrus as early as 1.5 years following first episode
of illness, as well as reduced volume in left Heschl’s gyrus
and left planum temporale at 1.5 years follow-up.
39These
latter findings suggest that progressive changes occur very
early in the course of schizophrenia. 
Importantly, follow-up studies of chronic patients have
also shown progressive changes in gray matter, includ-
ing superior temporal gyrus.
40Thompson and colleagues
41
have also reported an accelerated decrease in gray mat-
ter volume in early-onset schizophrenia. Of particular
note, in a recent review of the literature, DeLisi et al
42
reviewed evidence for progressive changes in both
chronic and first-episode patients. They concluded that
progressive changes over time in chronic patients are far
less than what is observed in first-episode patients, again
underscoring the fact that progressive changes in the
early stages of illness may be more dramatic than
changes observed later in the course of the illness.
Translational research
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43 sheds further light on the issue
of progressive changes following first episode. This
review found that progressive changes following first
episode were more pronounced in the first 20 years and
less pronounced after this time period compared with
healthy controls. Of further note, the changes observed
included gray matter volume reductions in the frontal
and temporal lobes, as well as increased lateral ventri-
cles. In addition, these changes were associated with
more progressive changes associated with poor outcome,
more negative symptoms, and poor performance on neu-
rocognitive measures.
A review by Pantelis and coworkers
17 of longitudinal MRI
studies of first-episode patients, prodromal patients, and
high-risk individuals also suggests an acceleration of gray
matter reduction early in the course of illness. Specifically,
there is gray matter reduction in prefrontal regions, which
these investigators believe leads to further progressive
changes in medial temporal and orbitofrontal brain
regions. These investigators also interpret findings, to date,
as indicative of an early neurodevelopmental insult or
lesion that likely “renders the brain vulnerable to later
brain maturation processes” and which takes place during
adolescence or early adulthood. These interpretations are
reminiscent of Mednick and McNeil’s 1968 two-hit theory
of schizophrenia,
33 and Feinberg’s 1982
32 theory that schiz-
ophrenia results from abnormal synaptic pruning. 
The number of first-episode studies is, however, rela-
tively small compared with the number of chronic stud-
ies. Additionally, the selection of patients differs in that
some studies include patients that have been ill for sev-
eral years, and, while they may not be chronic per se,
they might be better classified as reflecting “early schiz-
ophrenia” rather than as first-episode schizophrenia.
Having said this, however, there are a number of high-
resolution longitudinal studies that have investigated
brain abnormalities at first episode of illness. Some,
including Gur and coworkers,
37 and Kasai and cowork-
ers,
39 are noted above. Another study by Lieberman et
al
44 reported larger lateral ventricles and reduced volume
of the hippocampus at baseline, but only increased lat-
eral ventricles at follow-up 1 year later. Whitford and
coworkers
45 evaluated whole brain in a follow-up study
of first-episode patients who were rescanned 2 years
later. These investigators reported widespread gray mat-
ter reduction in frontal, parietal, temporal lobe (includ-
ing superior temporal gyrus), cerebellum, and in portions
of the occipital lobe. 
Another interesting study by Nakamura and coworkers
46
showed reduced neocortical gray matter, larger sulcal
CSF, and increased lateral ventricles at 1.5-year follow-
up in first-episode schizophrenics, compared with con-
trols. Poorer outcome in this study was also associated
with brain changes over time in the first-episode
patients, whereas in first-episode patients with an affec-
tive disorder and psychotic features, there was an
increase in neocortical gray matter volume (3.6%) at fol-
low-up. These investigators concluded that the changes
observed in neocortical gray matter in the affective
group were likely not intrinsic to the disorder, but were
instead associated with medication effects. In contrast,
the changes observed at follow-up in the first-episode
schizophrenia sample were interpreted as being intrin-
sic to the disorder. These latter findings are consistent
with neuropil loss reported in postmortem studies.
34
To summarize, findings from longitudinal studies of first
episode schizophrenics suggest that brain abnormalities
are present at first episode, and that some brain regions
continue to show progression over a relatively short
period of time. The follow-up in such studies, however,
is variable and we therefore need more studies that fol-
low patients over longer periods of time with intervals
in between, ie, 10- to 15-year follow-up, with scans
repeated 1 to 2 years post-onset. While this is a daunting
task, it is necessary if we are to successfully delineate the
brain regions affected at illness onset, and to determine
which abnormalities are specific to schizophrenia, which
progress over time, and what the implications of pro-
gression versus nonprogression might be. Additionally,
because brain changes appear to be present in the early
post-onset period, this is an important period in which
to conduct research so as to understand better the
processes taking place and the possibilities for early
intervention.
Another area that needs further attention, and is dis-
cussed at further length in a separate review,
24 is the
study of cognitive impairments and clinical symptoms,
and their association with brain abnormalities, as well as
with progressive brain changes. While some studies
report associations between brain regions and clinical
and cognitive impairments (see reviews in refs 3,23-26),
there is evidence that early in the course of illness cog-
nitive and clinical symptoms may improve, while struc-
tural brain abnormalities are observed to progress. As
we have noted previously: it is “important to understand
why these two seemingly incongruous events take place,
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to timing and progression, possible underlying mecha-
nisms, and intervention and treatment strategies.”
24
Finally, as we learn more about brain abnormalities at first
episode of illness, it becomes clear that it is important to
learn also about brain abnormalities in individuals who
are at risk for developing schizophrenia, and prior to the
onset of illness. Focusing on what is known as “the pro-
dromal period” will also make it possible to characterize
a subset of individuals who are at risk and go on to
develop schizophrenia, versus another subset of individ-
uals who are at risk but who do not go on to develop
schizophrenia. A focus on this group of subjects will also
make it possible to learn more about the timing of brain
abnormalities in schizophrenia, and to begin to develop
putative brain markers or brain signatures that predispose
an individual to develop schizophrenia. Another approach
is to study family members of schizophrenic patients in
order to discern brain abnormalities that are associated
with genetically regulated variations in brain structure, but
which are neither necessary nor sufficient for the devel-
opment of psychosis. Some of these strategies, along with
recent findings, are reviewed, below. 
High-risk studies 
To address the question of “what is the timing of brain
abnormalities in schizophrenia?” it is useful to study
individuals who are at high risk for developing schizo-
phrenia, but who have not yet developed the disorder,
ie, before psychosis begins. As noted above, this can be
addressed to some extent with longitudinal studies, but
can also be addressed by studying individuals who are at
high risk for developing schizophrenia, as one can
observe whether or not there are brain abnormalities
present prior to onset of schizophrenia. This approach is
quite appealing given that there is evidence to suggest
that as many as 35% of individuals defined as being at
ultra high-risk for schizophrenia convert to schizophre-
nia within the first year of being indentified
17 (see also
discussion below). 
With respect to high-risk studies, two of the largest and
best known research programs come to mind. The first
is the Edinburgh High-Risk Study (EHRS),
47 which eval-
uates individuals at risk for developing schizophrenia.
The EHRS defines “at-risk” based on cognitive impair-
ment measures from the Structural Interview for
Schizotypy (SIS). Findings thus far indicate that indi-
viduals who are at risk and who also have schizotypal
features tend to have increased right prefrontal cortical
folding, which further predicts those individuals who
develop schizophrenia. These investigators speculate
that abnormalities in cortical folding reflect disordered
connectivity in the right prefrontal lobe. 
The second large research program to evaluate individ-
uals at risk for psychosis is the Melbourne Ultra High-
Risk Studies, in collaboration with the Personal
Assessment and Crisis Evaluation (PACE) clinic. This
study investigates individuals at risk for developing psy-
chosis. Pantelis and colleagues, (eg, ref 17) define individ-
uals at ultra-high risk (UHR) for developing psychosis on
the basis of several trait and state factors. As noted above,
from this sample of UHR individuals, 35% went on to
develop schizophrenia within 1 year. Those UHR indi-
viduals who go on to develop schizophrenia show medial
temporal and prefrontal (particularly orbitofrontal) brain
abnormalities, compared with UHR subjects who do not
develop schizophrenia. These investigators, also as noted
previously, suggest that the brain abnormalities observed
in those who transition to schizophrenia reflect abnormal
brain maturation, which occurs with other events such as
substance abuse, stress, etc, and likely involves early neu-
rodevelopmental insults to the brain. This abnormal mat-
uration might then render the brain vulnerable to later
abnormal processes, including accelerated gray matter
loss in frontotemporal regions, and abnormal connectiv-
ity in prefrontal brain regions. 
A focus on genetics in high-risk studies is also impor-
tant. For example, the effects of the catechol-O-
methyltransferase (COMT) gene on brain structure and
function in high-risk individuals, reported by the
Edinburgh group,
48 suggests that the risk of developing
schizophrenia in the high-risk group is increased in indi-
viduals with the COMT Val158Met polymorphism. Thus
subtyping of high-risk individuals based on putative
brain markers, genes, and outcome, while just beginning,
will be an important direction for future studies.
Family studies: genetic high risk studies
An area of further inquiry is whether or not there are
some brain abnormalities that are present in schizo-
phrenia which are also present in nonaffected family
members. Such findings would point to potential mark-
ers of genetic vulnerability to schizophrenia. In addition,
studying nonaffected family members avoids the con-
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studies of chronic patients. Further, studying this popu-
lation is independent of psychosis, thus avoiding the
possible neurotoxic effects of psychosis, which may be
brewing even in high-risk populations. Finally, a focus on
nonaffected family members makes it possible to study
genetic factors as well as environmental factors with
respect to their roles in the etiology of schizophrenia.
Most of the MRI studies that have investigated nonaf-
fected family members report the severity of brain
abnormalities to be midway between healthy controls
and patients with schizophrenia, and similar to what is
observed in high-risk individuals.
23-26 The brain region
most commonly reported as abnormal is the hippocam-
pus, although it should noted that the hippocampus is
also one of the most commonly investigated brain region
in the relatives of schizophrenic patients. 
In a recent meta-analysis study by Boos and colleagues,
49
25 MRI studies of nonaffected first-degree relatives of
patients with schizophrenia were reviewed. The main
finding was reduced left hippocampal volume, and
increased third ventricle volume. Perhaps not surpris-
ingly, hippocampal findings were associated with verbal
and declarative memory deficits, similar to findings in
schizophrenia. Szesko and coworkers,
50 in 2005, also
reported an association between hippocampal volume
and brain-derived neurotropic factor (BDNF) val66met
polymorphism in schizophrenia. Furthermore, in the
same year, Callicott and colleagues
51 reported that the
DISC1 gene was associated with both structural and
functional alterations in the hippocampus. 
Other brain regions that have been associated with unaf-
fected first-degree relatives of patients with schizophre-
nia include parahippocampal gyrus, which is also closely
interconnected with hippocampus, and the thalamus.
These findings provide additional evidence for vulnera-
bility to schizophrenia that is independent of psychosis. 
Moreover, despite the fact that there have also been
negative findings, and not all brain regions have been
evaluated in the family members of patients with schiz-
ophrenia, the findings are nevertheless instructive, with
the caveat that hippocampal abnormalities are not spe-
cific to schizophrenia. 
Summary
To summarize, MRI findings in schizophrenia provide
evidence that brain abnormalities involve multiple focal
brain regions. There is also strong evidence to suggest
that there are progressive changes that occur early in the
course of illness and far greater attention needs to be
given to research in this critical time period in order to
develop targeted treatments that may halt the progres-
sion of disease. It is also evident that those individuals in
the prodromal phase show brain abnormalities that are
similar to those observed in nonaffected relatives, but
are more attenuated than the abnormalities observed in
patients with schizophrenia. Understanding why some
at risk individuals who evince brain abnormalities con-
vert to schizophrenia while others do not will be an
important future area of scientific investigation. The
hope here is that what we learn from “nonconverters”
can lead to the development and implementation of new
treatments that are neuroprotective in nature and thus
may prevent the conversion to schizophrenia and per-
haps prevent further progression in those with a first
onset of illness. 
Diffusion imaging findings in schizophrenia
While a great deal of attention has focused on gray mat-
ter abnormalities in schizophrenia, more recently there
has been a growing interest in “the other half of the
brain”
52; white matter. This interest follows the advent of
a new tool, DTI, which makes it possible to quantify and
to visualize white matter structure. This ability was not
possible previously with conventional MRI, where white
matter appears quite homogeneous.
White matter is comprised primarily of myelinated axon
sheaths that form the infrastructure for the transmission
of signals between populations of neurons, which can be
proximal or distant spatially in the brain. These densely
packed fibers interconnect gray matter regions of the
brain and form neural circuits that, among other things,
subserve cognitive functions that we associate with being
human, ie, attention, motivation, emotion, awareness of
self and others, etc. Lesion studies provide a multitude
of examples of the consequences that result from dam-
age to white matter, including akinetic mutism and apha-
sia (see review in Kubicki
23). 
Another reason for interest in white matter is that the
multifocal nature of gray matter abnormalities in schiz-
ophrenia is consistent with earlier views of schizophre-
nia as a disturbance in the connections between brain
regions.
1-3, 23Weinberger and colleagues,
53 in fact, speculate
that temporal lobe abnormalities likely reflect a neu-
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bic and prefrontal regions. 
Additional reasons for investigating white matter
pathology in schizophrenia come from neuropatholog-
ical as well as genetic studies that suggest myelin
involvement in schizophrenia (see recent reviews in
refs 23-26). More specifically, oligodendrocytes, which
are cells that produce myelin and provide both protec-
tion and facilitation of communication between brain
regions, may be involved in the pathophysiology of
schizophrenia. The latter has been described by
Whitford et al
25 as possibly related to conduction veloc-
ity abnormalities that may affect the action potential as
it travels along myelinated axons,
54 which could lead to
modulations in the speed of conduction between spa-
tially disparate populations of neurons. As discussed by
Whitford et al, this could ultimately leading to confu-
sions as to the origins of neural signals, and possibly to
confusion when distinguishing between internally gen-
erated and externally generated events.
Evaluating white matter pathology may also shed
light on the pattern and number of gray matter
abnormalities observed in schizophrenia, including,
but not limited to, frontotemporal tracts. Further, a
focus on white matter fiber bundles is a move away
from evaluating isolated gray matter regions and a
move toward evaluating neural systems and networks
that are biological substrates of cognition, social cog-
nition, emotion, attention, and, in general, behavior.
DTI findings in schizophrenia
There are now more than 178 DTI studies of white mat-
ter pathology in schizophrenia (see also Figure 4). The
first DTI study, as noted previously, was by Buchsbaum
and coworkers.
22 These investigators evaluated whole
brain in a relatively small sample, ie, 5 chronic patients
and 6 controls. Other early studies were also relatively
small, with 20 or fewer patients. Even with these small
sample sizes, however, reductions in anisotropy were
reported within the majority of fasciculi (including fron-
totemporal, frontooccipital, temporo-occipital, thalam-
ocortical, and interhemispheric connections; see also sev-
eral recent reviews, eg, refs 23-26). 
A main focus of DTI studies in schizophrenia has been
fronto-temporal connections in the brain (see recent
reviews in refs 23-26). Kubicki et al,
55 from our labora-
tory, was one of the first to use DTI to investigate fron-
totemporal connections in schizophrenia. In this study
the uncinate fasciculus (UF) was investigated. This fiber
bundle connects orbitofrontal and inferior frontal gyri
with the anterior pole and the amygdala, and it is
involved functionally in decision making, autobiograph-
ical and episodic memory, as well as in social behavior.
These investigators reported a decrease in left>right FA
asymmetry in chronic patients compared with healthy
controls. This decreased FA asymmetry in the UF was
correlated with declarative-episodic verbal memory in
the patients, but not the controls. UF decrease has since
been confirmed in two whole brain studies that used
voxel based morphometry (VBM) measures.
56-57
Another frontotemporal white matter connection that
has been frequently investigated in schizophrenia is the
cingulum bundle (CB). This fiber tract connects paral-
imbic-neocortical brain regions, and it also interconnects
limbic structures including dorsolateral prefrontal cor-
tex, cingulate gyrus, parahippocampal gyrus, and amyg-
dala. The CB is involved in a number of functions,
including pain perception, emotion, self-monitoring, and
spatial orientation and memory. Kubicki and coworkers
58
reported reduced FA in CB in patients compared with
controls. Furthermore, FA was found to be correlated
with errors in executive functions relevant to perfor-
mance monitoring in schizophrenia. This finding has
been reported also by other investigators, eg, refs 59-61.
Another study by Mori et al
62 evaluated both UF and
CB in schizophrenia using VBM and also found FA
decreases which they then confirmed using region of
interest measures. These FA reductions were negatively
correlated with duration of illness, suggesting possible
medication-related white matter deterioration. 
Several other white matter tracts connecting frontotem-
poral lobes have also been investigated. These tracts
include the arcuate fasciculus (AF), a white matter fiber
tract connecting superior temporal and inferior parietal
regions with inferior frontal gyrus. This tract is important
in language processing. Findings in chronic schizophre-
nia have shown left-lateralized reductions in anisotropy
in this brain region (eg, refs 63-65). Another tract that
has shown FA reduction in schizophrenia is the inferior
longitudinal fasciculus (ILF), which connects the ante-
rior temporal with parietal and occipital regions.
66
Further, in a study that subdivided patients into those
with and without auditory hallucinations, FA was
reduced in the AF, UF, and ILF in patients without audi-
tory hallucinations, while FA was increased in the AF
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(compared with patients without hallucinations).
67These
findings, taken together, suggest that white matter fiber
bundles that connect the frontal and temporal lobes are
particularly abnormal in patients with schizophrenia. 
Other white matter fiber tracts that have been investi-
gated in schizophrenia include the anterior limb of the
internal capsule, the corpus callosum, occipital lobe
white matter, hippocampus, frontal white matter, pre-
frontal white matter, and the fornix (see recent reviews
in refs 23-26). 
Finally, while most DTI studies of white matter fiber
bundles have been conducted in patients with chronic
schizophrenia, at least 15 studies have focused on first-
episode patients with schizophrenia (see recent reviews
in refs 23-26). While the sample sizes have generally
been small, the results suggest that the FA abnormalities
are present in first-episode patients, but are milder than
those exhibited by chronic patients. Given the subtlety
of these DTI abnormalities at first episode, variability in
the methods used may have impacted the consistency of
the reported findings even more than in chronic patients.
Another line of research has focused on populations that
are in some way related to schizophrenia, in the hope of
better characterizing schizophrenia phenotypes. These
studies include subjects with increased risk for schizo-
phrenia, including prodromes, schizotypal personality
disorder, and velocardiofacial syndrome (see recent
reviews in refs 23-26). As with MRI studies, investigat-
ing subjects who are at greater risk for developing schiz-
ophrenia is an important line of research as it will likely
help to tease apart factors intrinsic to schizophrenia ver-
sus epiphenomena or factors necessary but not sufficient
for onset of illness. 
Diffusion tractography 
The DTI studies reviewed above used voxel-based mor-
phometry (VBM) and/or region of interest measures to
define the fiber tracts. Fiber tractography is a promising
new method to visualize white matter fiber bundles. This
method follows the trajectory of fiber bundles along the
principal diffusion direction, and provides an estimate
of the local diffusion properties in the tensor field. It is
important to point out, however, that at today’s image
resolution, this method is not able to trace along the tra-
jectories of individual axons. The main advantage of DTI
tractography, as compared with VBM and region-of-
interest methods, is that diffusion can be quantified
along entire fiber bundles. Furthermore, fascicle tribu-
taries that might be misregistered or even excluded dur-
ing the process of spatial normalization in VBM, can also
be tracked and quantified, as can crossing fiber bundles.
A great deal of work is currently underway in an effort
to move from one-tensor models of fiber tractography
to two-tensor models which are even more promising
with respect to dealing with fiber crossings, eg, ref 68. 
Jones et al published the first DTI tractography study in
schizophrenia.
69This has been followed by a small hand-
ful of tractography studies which suggest that the most
prominent white matter abnormalities in schizophrenia
are in connections between frontotemporal lobe, includ-
ing the UF and CB, and in the inferior and superior lon-
gitudinal fasciculi, and corpus callosum. 
DTI tractography is thus a promising tool to understand
how specific brain regions are connected, and to under-
stand further how this connectivity may be relevant to
functional abnormalities. It is a relatively new investiga-
tive tool that will likely be used more in the next few
years, particularly in conjunction with functional mea-
sures of the brain.
Implications and future directions for research
Based on a review of structural neuroimaging studies in
schizophrenia, it is clear that schizophrenia is a brain dis-
order that shows marked, albeit subtle, neuroanatomical
abnormalities that are multifocal in nature and which
likely involve brain circuits and networks which subserve
cognition and behavior. Evidence also suggests that
schizophrenia involves a disorder of neural and cogni-
tive integration, an idea that has long been proposed in
the schizophrenia literature. Some of the more recent
theories that touch upon disordered integration include
the dysmetria theory proposed by Andreasen et al,
70 the
failure of integration proposed by Gruzelier et al,
71
Feinberg’s
30 theory of aberrant synaptic pruning,
Friston’s
72 theory of abnormal synaptic modulation, and
Bartzokis’s
73 theory which suggests that the underlying
cause of neural integration may be abnormalities in
myelination processes that occur in the periadolescent
period. 
Despite promising findings, however, we are still far
from understanding the neuropathology of schizophre-
nia. Some of the outstanding questions that remain to be
addressed if we are to understand the etiology of schiz-
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first occur? What are the microstructural underpinnings
of these structural brain abnormalities? Is there a
causative relationship between gray matter abnormali-
ties observed with MRI and white matter abnormalities
observed with DTI? Do all of the structural brain abnor-
malities associated with schizophrenia progress with ill-
ness, or are some stable over time? Is it possible to arrest
these progressive neuroanatomical changes once they
have begun? As brain abnormalities in patients with
schizophrenia have been shown to be associated with
cognitive and clinical symptoms, how do we understand
improvement in cognitive and clinical symptoms which
are often concomitant with progressive volume reduc-
tions following the first episode of illness? What is the
relationship between the structural brain abnormalities
characteristic of schizophrenia and the equally well doc-
umented functional brain abnormalities (eg, such as
observed with PET, fMRI, etc)? Can neuroanatomical,
neuropsychological, or clinical phenotypes be used to
predict who will go on to develop schizophrenia and
who will not? These are among the questions that we
need to address in future studies.
While these questions are daunting, there is nonetheless
reason for optimism. The technological advances in neu-
roimaging that have led to new discoveries about the
brain and its role in schizophrenia will continue.
Additionally, future studies will likely involve combining
multiple in vivo methodologies (ie, structural MRI, MTR,
DTI on the one hand, and functional MRI, PET, and
spectroscopy on the other) in order to investigate brain
systems and networks in schizophrenia, and their func-
tion and dysfunction. Such studies are already beginning
to emerge, and they will likely replace single-modality
approaches within the next few years. As stated most
recently: “This change from single to multimodal imag-
ing will significantly increase our understanding of the
relationship between functional and structural brain
abnormalities in schizophrenia, and also lay the founda-
tion for linking such findings to signature cognitive
impairments and susceptibility genes.”
24The next decade
will thus be an exciting one. New developing technolo-
gies will be used in a multimodal fashion across patients’
lifespans (ie, from prodrome to first episode to chronic),
which will lead to a better understanding of what brain
systems and networks are abnormal in schizophrenia, and
when these abnormalities occur. Such knowledge will, in
turn, lead to insight into why these abnormalities occur
and how they might best be treated. Our common hope
is that this will lead to a greater understanding of brain
abnormalities in schizophrenia, with a particular focus on
the critical period following first episode, where pro-
gressive changes in the brain are most profound. This
may lead to a greater understanding of cognitive impair-
ments, clinical symptoms, and genetic underpinnings of
schizophrenia, which will ultimately lead to more ratio-
nal and efficacious treatment strategies than are avail-
able today. ❏
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Neuroimágenes estructurales en la 
esquizofrenia: desde la metodología hasta 
la comprensión de los tratamientos
Desde un punto de vista histórico Kraepelin for-
muló la hipótesis que la demencia precoz se pro-
ducía por un daño en la corteza cerebral, más espe-
cíficamente en las cortezas frontal y temporal. Sin
embargo, sólo recientemente se ha podido dispo-
ner de herramientas para evaluar esta hipótesis.
Desde hace más de un siglo que ya se sabe que la
esquizofrenia es un trastorno cerebral. Este conoci-
miento procede de importantes avances en la tec-
nología de imágenes –que incluyen la tomografía
axial computarizada, las imágenes de resonancia
magnética y las imágenes de difusión- todos los
cuales aportan una visión, in vivo, sin precedentes
de las estructuras neuroanatómicas. En este artículo
se revisan las evidencias de las anormalidades
estructurales de las neuroimágenes, comenzando
con evidencias de alteraciones cerebrales focales,
principalmente en la sustancia gris y continuando
con las investigaciones para identificar anormali-
dades en los sistemas y circuitos cerebrales, focali-
zándose en el daño en las conexiones con la sus-
tancia blanca del cerebro. Luego se revisan futuras
líneas de investigación que requieren ser explora-
das y desarrolladas para traducir el conocimiento
actual en una comprensión de la neurobiología de
la esquizofrenia, que puede traducirse en nuevos
tratamientos. 
Neuro-imagerie structurelle dans la 
schizophrénie : des méthodes à la 
compréhension et aux traitements
Historiquement, Kraepelin a émis l’hypothèse que
la démence précoce résultait d’une lésion du cortex
cérébral, plus particulièrement du cortex frontal et
du cortex temporal. Ce n’est cependant que récem-
ment seulement que des outils ont permis de tester
cette hypothèse. Maintenant, plus d’un siècle plus
tard, nous savons que la schizophrénie est un
trouble cérébral grâce à des avancées décisives en
imagerie, comprenant la tomographie axiale numé-
risée, l’imagerie par résonance magnétique et l’ima-
gerie de diffusion, toutes fournissant un aperçu
sans précédent des structures neuroanatomiques in
vivo. Nous présentons ici les données scientifiques
en faveur de l'existence d'anomalies  identifiées par
la neuro-imagerie structurelle, en commençant par
les anomalies cérébrales focales, tout d’abord dans
la substance grise et en poursuivant par l’identifi-
cation des anomalies des circuits et des systèmes
cérébraux en s’attachant en particulier aux lésions
des connexions  de la substance blanche cérébrale.
Puis nous abordons les futures perspectives à explo-
rer  afin de transformer notre connaissance actuelle
en une compréhension de la neurobiologie de la
schizophrénie, afin de développer  par la suite de
nouveaux traitements. 
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